A Health Outcome Assessment of the Cardio Metabolic Mission Health Program at Novartis

• Published in: Journal of occupational and environmental medicine 2011-06, Vol.53 (6), p.647-652
• Main Authors: Mauceri, Edward, Bienkowski, Catherine, Hanson, Kristin A., Doyle, Joseph J., Jacbon, James, Bramer, Susan
• Format: Article
• Language: English
• Subjects: Adult; Biological and medical sciences; Blood pressure; Body Mass Index; Cardiovascular Diseases - complications; Cardiovascular Diseases - prevention & control; Diabetes; Diabetes Mellitus - prevention & control; Female; Health Behavior; Health Education - methods; Health Knowledge, Attitudes, Practice; Health Promotion - methods; Health Status; Health Status Indicators; Humans; Hyperlipidemias - prevention & control; Hypertension; Hypertension - prevention & control; Male; Medical sciences; Metabolic Syndrome - complications; Metabolic Syndrome - therapy; Middle Aged; Miscellaneous; Obesity; Obesity - prevention & control; Occupational health; Occupational Health Services - methods; Occupational medicine; ORIGINAL ARTICLES; Outcome Assessment (Health Care); Prospective Studies; Public health. Hygiene-occupational medicine; Risk Factors; Wellness programs
• ISSN: 1076-2752; 1536-5948
• DOI: 10.1097/JOM.0b013e31821b7ade

Objective: To assess the impact of the Novartis Cardio Metabolic Program—an education, awareness, and health management initiative—on hypertension, hyperlipidemia, diabetes mellitus, and obesity within the Novartis employee population. Methods: A prospective, 6-month pre-/post assessment to determine improvement in blood pressure (BP) control and risk factors after implementation of Novartis Cardio Metabolic. Results: A total of 238 subjects with cardiovascular risk factors participated. In the hypertension cohort, overall BP control improved from 38% at baseline to 79% at follow-up (P < 0.0001). In the hyperlipidemia cohort, low-density lipoprotein cholesterol control improved significantly between baseline and study end (22% to 34%, P = 0.0004). In the diabetes mellitus cohort, the rate of glycosylated hemoglobin control increased from 83.7% to 86.2% (P = 0.69). There was a significant decrease in body mass index at follow-up (P < 0.0001). Conclusion: Novartis Cardio Metabolic educational and health interventions helped to improve health awareness among Novartis employees.